Market Access/ News/ News Janssen, Legend CAR-T therapy CARVYKTI gets FDA nod Eloise McLennan CAR-T therapies, Janssen, Legend Biotech, multiple myeloma, pharma 0 Comment The US Food and Drug Administration (FDA) has approved a new cell-based therapy for blood cancer, developed by Share X Janssen, Legend CAR-T therapy CARVYKTI gets FDA nod https://pharmaphorum.com/news/janssen-legend-cart-carvykti-fda/
News/ News/ Sales and Marketing/ Top stories Drama as J&J partner Legend’s CEO is detained after Chinese customs raids Phil Taylor Frank Zhang, GenScript, investigation, Johnson & Johnson, Legend Biotech 0 Comment Just a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to Share X Drama as J&J partner Legend’s CEO is detained after Chinese customs raids https://pharmaphorum.com/news/drama-as-jj-partner-legends-ceo-is-detained-after-chinese-customs-raids/
CAR-T therapies, Janssen, Legend Biotech, multiple myeloma, pharma
0 Comment
